MYMX

Healthcare Biotechnology

Mymetics Corporation

$0.00

+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap

45.564

Avg Volume

EPS

-$106.70

52W High

$0.00

52W Low

$0.00

Div. Yield

0.0%

Valuation

P/B Ratio

-0.00

P/S Ratio

0.00

EV/EBITDA

-42.88

EV/Revenue

140.81

Margins

Gross Margin (42.2%)

Operating Margin (1120.6%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

(73.8%)

Return on Assets

(29.1%)

Liquidity & Leverage

Current Ratio

0.00

Quick Ratio

0.00

Total Cash

62,000

Total Debt

75.11M

About

Mymetics Corporation engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, and malaria. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; and national institutes of health. The company was formerly known as ICHOR Corporation and changed its name to Mymetics Corporation in July 2001. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland.